Clinical Trials Browser

Phase 2 × Fulvestrant × Genitourinary × Clear all

Biliary Tract Neoplasms, Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Uterine Cervical Neoplasms, Urologic Neoplasms, Uterine Neoplasms, Colorectal Neoplasms

NCT04557449 2025-10-01

CDK4i

Phase 2 Active not recruiting

362 enrolled

BreastGastrointestinalGenitourinarySarcomaThoracic

Adenocarcinoma of Lung, Breast Neoplasms, Liposarcoma, Prostatic Neoplasms, Colorectal Neoplasms

NCT00217464 2015-04-16

Fulvestrant in Treating Patients With Recurrent Prostate Cancer

Phase 2 Terminated

17 enrolled 6 charts

Genitourinary

Prostatic Neoplasms

NCT00476645 2014-08-05

Fulvestrant in Hormone Refractory Prostate Cancer

Phase 2 Completed

10 enrolled 8 charts

Genitourinary

Prostatic Neoplasms

NCT00244998 2013-03-08

Fulvestrant in Treating Patients With Advanced Prostate Cancer

Phase 2 Completed

20 enrolled

Genitourinary

Prostatic Neoplasms

Clinical Trials

Basket Study of Tucatinib and Trastuzumab in Solid Tumors With HER2 Alterations

CDK4i

Fulvestrant in Treating Patients With Recurrent Prostate Cancer

Fulvestrant in Hormone Refractory Prostate Cancer

Fulvestrant in Treating Patients With Advanced Prostate Cancer